In summary, resveratrol combined with cisplatin produced a synergistic effect on the inhibition of breast cancer cell viability, inhibits breast cancer MDA231 cell migration and invasion through EMT regulated by PI3K/AKT, Smad, NF-κB, JNK, and ERK. Here, NFKB1 is linked to breast carcinoma.